Literature DB >> 27747490

Marijuana Use and Type 2 Diabetes Mellitus: a Review.

Stephen Sidney1.   

Abstract

Marijuana is used by millions of people, with use likely to increase in the USA because of the trend towards increased decriminalization and legalization. Obesity and diabetes mellitus (DM) rates have increased dramatically in the USA over the past 30 years, with a recent estimate of 29 million individuals with DM. Because there is a plausible link between marijuana use and diabetes due to the known effects of cannabinoids on adipose tissue and glucose/insulin metabolism, it is important to study and understand how marijuana use is related to obesity and diabetes. This paper provides background on the human endocannabinoid system and studies of the association of marijuana use with body mass index/obesity, metabolic syndrome, prediabetes, and diabetes. The studies to date have shown that marijuana use is associated with either lower odds or no difference in the odds of diabetes than non-use.

Entities:  

Keywords:  Cannabis; Diabetes; Endocannabinoid; Epidemiology; Marijuana

Mesh:

Year:  2016        PMID: 27747490     DOI: 10.1007/s11892-016-0795-6

Source DB:  PubMed          Journal:  Curr Diab Rep        ISSN: 1534-4827            Impact factor:   4.810


  21 in total

1.  Body mass index and marijuana use.

Authors:  Matthew Warren; Kimberly Frost-Pineda; Mark Gold
Journal:  J Addict Dis       Date:  2005

Review 2.  Cannabinoids and endocannabinoids in metabolic disorders with focus on diabetes.

Authors:  Vincenzo Di Marzo; Fabiana Piscitelli; Raphael Mechoulam
Journal:  Handb Exp Pharmacol       Date:  2011

3.  Cannabis Smoking and Diabetes Mellitus: Results from Meta-analysis with Eight Independent Replication Samples.

Authors:  Omayma Alshaarawy; James C Anthony
Journal:  Epidemiology       Date:  2015-07       Impact factor: 4.822

4.  Marijuana use, diet, body mass index, and cardiovascular risk factors (from the CARDIA study).

Authors:  Nicolas Rodondi; Mark James Pletcher; Kiang Liu; Stephen Benjamin Hulley; Stephen Sidney
Journal:  Am J Cardiol       Date:  2006-06-19       Impact factor: 2.778

5.  Triggering myocardial infarction by marijuana.

Authors:  M A Mittleman; R A Lewis; M Maclure; J B Sherwood; J E Muller
Journal:  Circulation       Date:  2001-06-12       Impact factor: 29.690

Review 6.  Cannabis use and obesity and young adults.

Authors:  Mohammad R Hayatbakhsh; Michael J O'Callaghan; Abdullah A Mamun; Gail M Williams; Alexandra Clavarino; Jake M Najman
Journal:  Am J Drug Alcohol Abuse       Date:  2010-10-12       Impact factor: 3.829

7.  Determination and characterization of a cannabinoid receptor in rat brain.

Authors:  W A Devane; F A Dysarz; M R Johnson; L S Melvin; A C Howlett
Journal:  Mol Pharmacol       Date:  1988-11       Impact factor: 4.436

8.  Molecular characterization of a peripheral receptor for cannabinoids.

Authors:  S Munro; K L Thomas; M Abu-Shaar
Journal:  Nature       Date:  1993-09-02       Impact factor: 49.962

9.  Metabolic Syndrome Among Marijuana Users in the United States: An Analysis of National Health and Nutrition Examination Survey Data.

Authors:  Denise C Vidot; Guillermo Prado; WayWay M Hlaing; Hermes J Florez; Kristopher L Arheart; Sarah E Messiah
Journal:  Am J Med       Date:  2015-11-05       Impact factor: 4.965

10.  Marijuana use and risk of prediabetes and diabetes by middle adulthood: the Coronary Artery Risk Development in Young Adults (CARDIA) study.

Authors:  Michael P Bancks; Mark J Pletcher; Stefan G Kertesz; Stephen Sidney; Jamal S Rana; Pamela J Schreiner
Journal:  Diabetologia       Date:  2015-09-13       Impact factor: 10.460

View more
  5 in total

1.  Cannabis use prevalence among individuals with diabetes: The National Survey on Drug Use and Health, 2005-2018.

Authors:  Trevor R Sexton; Omayma Alshaarawy
Journal:  Drug Alcohol Depend       Date:  2020-05-15       Impact factor: 4.492

2.  Chronic pain patients' perspectives of medical cannabis.

Authors:  Brian J Piper; Monica L Beals; Alexander T Abess; Stephanie D Nichols; Maurice W Martin; Catherine M Cobb; Rebecca M DeKeuster
Journal:  Pain       Date:  2017-07       Impact factor: 6.961

3.  Cannabis use as a factor of lower corpulence in hepatitis C-infected patients: results from the ANRS CO22 Hepather cohort.

Authors:  Tangui Barré; Fabrice Carrat; Clémence Ramier; Hélène Fontaine; Vincent Di Beo; Morgane Bureau; Céline Dorival; Dominique Larrey; Elisabeth Delarocque-Astagneau; Philippe Mathurin; Fabienne Marcellin; Ventzislava Petrov-Sanchez; Carole Cagnot; Patrizia Carrieri; Stanislas Pol; Camelia Protopopescu
Journal:  J Cannabis Res       Date:  2022-06-11

4.  In Vivo Cannabidiol Treatment Improves Endothelium-Dependent Vasorelaxation in Mesenteric Arteries of Zucker Diabetic Fatty Rats.

Authors:  Amanda J Wheal; Khalid Jadoon; Michael D Randall; Saoirse E O'Sullivan
Journal:  Front Pharmacol       Date:  2017-05-18       Impact factor: 5.810

5.  Cannabis use is associated with reduced prevalence of non-alcoholic fatty liver disease: A cross-sectional study.

Authors:  Adeyinka Charles Adejumo; Samson Alliu; Tokunbo Opeyemi Ajayi; Kelechi Lauretta Adejumo; Oluwole Muyiwa Adegbala; Nnaemeka Egbuna Onyeakusi; Akintunde Micheal Akinjero; Modupeoluwa Durojaiye; Terence Ndonyi Bukong
Journal:  PLoS One       Date:  2017-04-25       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.